-- 
Israel Stocks: Delek Automotive, Glycominds, Habas, Kamor, Ophir

-- B y   S u s a n   L e r n e r
-- 
2011-07-10T16:05:23Z

-- http://www.bloomberg.com/news/2011-07-10/israel-stocks-delek-automotive-glycominds-habas-kamor-ophir.html
Israel â€™s TA-25 Index increased to
the highest level since May 22, advancing 0.7 percent to
1,268.44 at the 4:30 p.m. close in  Tel Aviv . Investors traded
about 888.5 million shekels ($261.3 million) in shares and
convertible securities.  The following stocks rose or fell today. Symbols are in
parentheses.  Glycominds Ltd. (GLCM IT) soared the most since shares
listed in March, climbing 18 percent to 1.227 shekels. The
molecular-diagnostics company said it received approval from
three more U.S. states to market its multiple sclerosis blood
test.  Habas H.Z. Investments (1960) Ltd. (HBS IT) advanced 4.7
percent to 8.269 shekels, the highest since May 1. The board of
the international investment and holding company approved paying
an annual dividend of 25 percent of profit and declared a 30
million-shekel distribution, payable Aug. 1.  Separately, the company said it plans a bond sale and
exchange offer for some of its outstanding bonds.  Kamor Motors Ltd. (KMRS)   surged the most since at least
November 2006 when Bloomberg began tracking the shares, soaring
31 percent to 16.40 shekels. The controlling shareholders of the
importer of BMW vehicles to Israel said they were in talks to
sell their stakes to  Delek Automotive Systems Ltd. (DLEA)  
based on a value of 245 million shekels ($72 million).  Kamor
Ltd. (KMOR)  , which owns about 64 percent of Kamor Motors,
jumped 5.1 percent to 9.461 shekels, the highest since May 2010.
Delek Automotive increased 3.6 percent, the most in a week, to
37.98 shekels.  Medigus Ltd. (MDGS)   climbed 16 percent to 0.946 shekel,
the biggest increase since August 2009. The developer of
procedures and devices to treat gastro-esophageal reflux disease
received the preliminary results of the final clinical trial of
its endoscopy system.  Ophir Optronics Ltd. (OPIR)   advanced the most since at
least February 1996, when Bloomberg began tracking the shares,
rising 73 percent to 25.90 shekels. The maker of optical
instruments agreed to be acquired by Newport Corp. for $230
million.  To contact the reporter on this story:
 Susan Lerner  in Jerusalem at 
 slerner2@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  